Abstract
Congenital rubella syndrome (CRS) results from fetal infection with rubella virus following primary maternal infection. CRS was initially described in 1941 by Gregg, an Australian ophthalmologist who noted cataracts and congenital heart defects among 71 infants born to mothers who had rubella infection during pregnancy. CRS did not gain widespread recognition until the worldwide rubella pandemic from 1962 to 1964. In the United States during that time, 20,000 infants developed CRS and an additional 10,000 stillbirths occurred. Live-attenuated rubella vaccine was developed in 1969, and routine immunization of young children and at-risk women of childbearing age has markedly reduced the incidence of CRS. Rubella and congenital rubella syndrome were declared eradicated in the United States in 2004 and in the Americas in 2015. However, rubella remains common in other parts of the world, and imported cases of CRS are still seen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lambert N, Strebel P, Orenstein W, Icenogle J, Poland GA. Rubella. Lancet. 2015;385:2297–307.
Kanaan MN, Farrington CP. Matrix models for childhood infections: a Bayesian approach with applications to rubella and mumps. Epidemiol Infect. 2005;133:1009–21.
Lebo EJ, Kruszon-Moran DM, Marin M, et al. Seroprevalence of measles, mumps, rubella, and varicella antibodies in the United States population, 2009-2010. Open Forum Infect Dis. 2015;20:ofv006.
Hyde TB, Kruszon-Moran D, McQuillan GM, et al. Rubella immunity levels in the United States population: has the threshold of viral elimination been reached? Clin Infect Dis. 2006;43(S3):S146–50.
Dykewicz CA, Kruszon-Moran D, McQuillan GM, et al. Rubella seropositivity in the United States, 1988-1994. Clin Infect Dis. 2001;33:1279–86.
Seither R, Calhoun K, Street EJ, et al. Vaccination coverage for selected vaccines, exemption rates, and provisional enrollment among children in kindergarten—United States, 2016-17 school year. MMWR. 2017;66:1073–80.
Walker TY, Elam-Evans LD, Singleton JA, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years—United States, 2016. MMWR. 2017;66:874–82.
Papania MJ, Wallace GS, Rota PA, et al. Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience. JAMA Pediatr. 2014;168:148–55.
Vynnycky E, Adams EJ, Cutts FT, et al. Using seroprevalence and immunization coverage data to estimate the global burden of congenital rubella syndrome, 1996-2010: a systematic review. PLoS One. 2016;11:e0149160.
Cradock-Watson JE, Miller E, Ridehalgh MK. Detection of rubella virus in fetal and placental tissues and in the throats of neonates after serologically confirmed rubella in pregnancy. Prenat Diagn. 1989;9:91–6.
Miller E, Cradock-Watson JE, Pollock TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet. 1982;2:781–4.
Collins IS. The incidence of congenital malformations following maternal rubella at various stages of pregnancy. Med J Aust. 1953;2:456–8.
Gregg NM. Congenital cataract following German measles in the mother. Trans Ophthal Soc Austr. 1941;3:35–44.
Givens KT, Lee DA, Jones T, Ilstrup DM. Congenital rubella syndrome: ophthalmic manifestations and associated systemic disorders. Br J Opthalmol. 1993;77:358–63.
Overall JC. Intrauterine virus infections and congenital heart disease. Am Heart J. 1972;84:823–33.
Wild NJ, Sheppard S, Smithells RW, Holzel H, Jones G. Onset and severity of hearing loss due to congenital rubella infection. Arch Dis Child. 1989;64:1280–3.
Munoz FM. Maternal immunization: an update for pediatricians. Pediatr Ann. 2013;42:153–8.
Bullens D, Smets K, Vanhaesebrouck P. Congenital rubella syndrome after maternal reinfection. Clin Pediatr. 2000;39:113–6.
Centers for Disease Control and Prevention. Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR Recomm Rep. 2001;50(RR-12):1–23.
Grose C, Itani O, Weiner CP. Prenatal diagnosis of fetal infection: advances from amniocentesis to cordocentesis—congenital toxoplasmosis, rubella, cytomegalovirus, varicella virus, parvovirus, and human immunodeficiency virus. Pediatr Infect Dis J. 1989;8:459–68.
Jin L, Thomas B. Application of molecular and serological assays to case based investigations of rubella and congenital rubella syndrome. J Med Virol. 2007;79:1017–24.
Hubschen JM, Bork SM, Brown KE, et al. Challenges of measles and rubella laboratory diagnostics in the era of elimination. Clin Microbiol Infect. 2017;23:511–5.
Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2013;62(RR-4):13.
Centers for Disease Control and Prevention. Rubella vaccination during pregnancy—United States, 1971-1988. MMWR. 1989;38:289–93.
Yamada T, Mochizuki J, Hanaoka M, et al. Effects of campaign for postpartum vaccination on seronegative rate against rubella among Japanese women. BMC Infect Dis. 2014;14:152.
Vilajeliu A, Garcia-Basteiro AL, Valencia S, et al. Rubella susceptibility in pregnant women and results of a postpartum immunization strategy in Catalonia, Spain. Vaccine. 2015;33:1767–72.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Cantey, J.B. (2018). Rubella. In: Cantey, J. (eds) Neonatal Infections. Springer, Cham. https://doi.org/10.1007/978-3-319-90038-4_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-90038-4_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90037-7
Online ISBN: 978-3-319-90038-4
eBook Packages: MedicineMedicine (R0)